Robert Rosenfield to Hydroxyprogesterones
This is a "connection" page, showing publications Robert Rosenfield has written about Hydroxyprogesterones.
Connection Strength
0.228
-
Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
Score: 0.130
-
Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. J Clin Endocrinol Metab. 1994 Jun; 78(6):1336-40.
Score: 0.031
-
Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1993 Feb; 76(2):450-5.
Score: 0.029
-
Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report. J Reprod Med. 1987 May; 32(5):363-9.
Score: 0.019
-
Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
Score: 0.007
-
Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
Score: 0.005
-
Plasma androgens in women with acne vulgaris. J Invest Dermatol. 1983 Jul; 81(1):70-4.
Score: 0.004
-
Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab. 1981 Jun; 52(6):1129-36.
Score: 0.003